Optegra Eye Healthcare (“Optegra”) acquired Top Esthetic (“TE”) in August 2021 and Vidium Medica (“Vidium”) in December 2021. TE and Vidium are leading ophthalmology providers in the Czech and Polish markets respectively.
Optegra generates circa £100 million sales and is a leading pan-European ophthalmology group with 27 eye care hospitals and 26 outpatient facilities. It has operations across the United Kingdom, Czech Republic and Poland. Optegra provides a range of critical eye-care services including cataract surgeries and age-macular degeneration as well as leading innovative vision correction procedures. The business provides leading eye-care to publicly funded national healthcare systems such as the NHS as well as to self-pay patients. The group holds top 1 or 2 market positions in each of the countries in which it operates. Optegra has an exceptional clinical and management team and well invested facilities with ample capacity to support future growth.
The acquisition of TE and Vidium is a further step in supporting the strategic vision for the group as a market-leading provider of standardized pathways driving clinical outcomes in ophthalmology care across Europe.
TE, founded in 2009, operates a network of eye clinics, and outpatient facilities in Prague and Mladá Boleslav, Czech Republic. It provides cataract treatments, refractive surgeries as well treating age-macular degeneration.
Vidium Medica, founded in 2016, provides vision correction and cataract treatments across two clinics in Poland.
Optegra UK recently opened its ninth eye care hospital in Newcastle, England to support local NHS patients.
For further information of Optegra, please visit www.optegra.com
